SCHEMBL2856440

SCHEMBL2856440

COc1ccc(CC/C=C(\NC(=O)OCc2ccccc2)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GPR52 Q9Y2T5 1/20 0.47
ALDH1A1 P00352 4/20 0.47
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
GAA P10253 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ACHE P22303 1/20 0.46
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
MIF P14174 1/20 0.44
PLAAT3 P53816 1/20 0.44
PLAAT5 Q96KN8 1/20 0.44
PLAAT2 Q9NWW9 1/20 0.44
PLAAT4 Q9UL19 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856445 1.00 ATM (0.50) ATMMEN1KMT2AGPR52ALDH1A1
SCHEMBL2855442 0.90 CA12 (0.48) ALDH1A1RAB9ANPC1CA1CA2
SCHEMBL2855446 0.90 CA12 (0.48) ALDH1A1RAB9ANPC1CA1CA2
SCHEMBL4248329 0.86 GPR52 (0.43) MEN1KMT2AGPR52RAB9ANPC1
SCHEMBL4248334 0.86 GPR52 (0.43) MEN1KMT2AGPR52RAB9ANPC1
SCHEMBL2851837 0.83 TAAR1 (0.44) MEN1KMT2ARAB9ANPC1TAAR1
SCHEMBL2851831 0.83 TAAR1 (0.44) MEN1KMT2ARAB9ANPC1TAAR1
SCHEMBL16468538 0.82 ATM (0.64) ATMMEN1KMT2AALDH1A1RAB9A
SCHEMBL3349349 0.82 ATM (0.50) ATMMEN1KMT2AALDH1A1RAB9A
SCHEMBL3349346 0.82 ATM (0.50) ATMMEN1KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651596-B1 NOVEL DERIVATIVES OF 4,4'-DITHIOBIS-(3-AMINOBUTANE-1-SULFONATES) AND COMPOSITIONS COMPRISING THE SAME INST NAT SANTE RECH MED (FR) 2010-01-13 EP disclosed
US-7582797-B2 Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2009-09-01 US disclosed
US-20060205695-A1 Novel derivatives of 4,4' dithiobis-(3-aminobutane-1-1-sulfonates) and compositions comprising the same INSTITUT NATINAL DE LA SANTE ET DE LA RECHERECHE (INSERM) (FR) 2006-09-14 US disclosed
EP-1651596-A1 NOVEL DERIVATIVES OF 4,4'-DITHIOBIS-(3-AMINOBUTANE-1-SULFONATES) AND COMPOSITIONS COMPRISING THE SAME INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2006-05-03 EP disclosed
WO-2005014535-A1 NOVEL DERIVATIVES OF 4,4'-DITHIOBIS-(3-AMINOBUTANE-1-SULFONATES) AND COMPOSITIONS COMPRISING THE SAME INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2005-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205695-A1 Novel derivatives of 4,4' dithiobis-(3-aminobutane-1-1-sulfonates) and compositions comprising the same AGTR1, AGTR2, AGT ATM 1309/4885MEN1 2440/4885KMT2A 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.